GSK3B and depressive symptom measurement: In agreement with a mechanistic role of GSK3 in mood disorders, GSK3β was found to be reduced and less phosphorylated in the prefrontal cortex of post-mortem brain samples of patients with depression (Karege et al. 2007; Karege et al. 2021; Pandey et al. 2015).